EMERGERS

Equity Research of
Nordic Growth Companies

Home

Författare: johan@emergers.se

QLUCORE: Delayed CE approval suggests upcoming need for additional financing

2023-06-01• Analys, Research

With BSI as Notified Body, Qlucore now expects to obtain CE certification for its Qlucore Diagnostics ALL application in February 2025....

Read More →

KEBNI: Broad support for long-term revenue target but cash an increasing concern

2023-05-24• Analys, Research

KebNi reported an 80% revenue growth in Q1’23, to SEK 10.9m, largely due to sales of satellite antennas to IAI. Despite a variety of...

Read More →

NANEXA: Solid progress in development into 2023, with funding needs on the horizon

2023-05-05• Analys, Research

After positive pre-clinical results in rats with NEX-22 (for treatment of type 2 diabetes) in Q1, we now see results from phase I for...

Read More →

BONZUN: Six deals to date validate scale-up with municipalities for DTx service Evolve

2023-04-18• Research

On the back of the framework agreement with the Swedish Security Council (TRR) for Bonzun’s digital CBT service Evolve signed in Q4’22,...

Read More →

CAPSEK: Övertecknad emission i CapSeks Klash Studio

2023-03-31• Okategoriserade

CapSeks portföljbolag Klash Studio fullbordade nyligen en emission med deltagande från CapSek samt flera namnkunniga investerare med...

Read More →

Interview | SIMRIS GROUP: CEO Julian Read about venture into ADCs and CDMO deal with Lonza Ltd

2023-03-08• Okategoriserade

Interview with SIMRIS GROUP CEO Julian Read about the venture into ADCs, the CDMO deal with Lonza Ltd and where he expects that Simris...

Read More →

GRANGEX: Anglo American-deal provides significant validation and financing for ambitious growth plan

2023-03-08• Analys, Research

GRÄNGESBERG EXPLORATION After the DFS for Dannemora in Dec 2022 showing an IRR of 27% after tax, GRANGEX has now signed a two-fold deal...

Read More →

Video Interview | KEBNI: Targeting capacity of 10,000 IMUs per year in 2025

2023-03-02• Analys, Research

With another NLAW order to Saab from Finland of SEK 400m, KebNi is now targeting a production capacity of 10,000 IMUs by 2025 and expect...

Read More →

QLUCORE: Important milestone passed on the road to a more individualized cancer care

2023-03-02• Analys, Research

The progress in Q3’22/23 (Nov–Jan) continues to support the long term case we’re seeing in Qlucore, where the company aims to provide...

Read More →

KEBNI: Great NLAW backdrop yet to translate to the KebNi share

2023-02-27• Analys, Research

With another NLAW order, from Finland of SEK 400m, Saab’s delivery timeline support a revenue scenario for KebNi that exceeds its own...

Read More →
CONTACT

Johan Widmark

Mail: johan@emergers.se
Tel: +46739196641

Östermalmsgatan 26A
114 26 Stockholm, Sweden

For new research on growth stocks, sign up to our newsletter